Source - SMW
Cello Group expects results for the year ended 31 Dec to be in line with forecasts.

The group said it traded well in 2017, with continued strong overall and like-for-like growth from Cello Health. 

The group also said it had successfully integrated two US acquisitions into Cello Health.




At 9:27am: (LON:CLL) Cello Group PLC share price was +0.5p at 126p